IRIS
DELLA PORTA, MATTEO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.039
EU - Europa 2.118
AS - Asia 1.641
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
SA - Sud America 3
Totale 6.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.000
CN - Cina 1.460
IE - Irlanda 594
UA - Ucraina 405
FI - Finlandia 358
DE - Germania 221
IT - Italia 178
SE - Svezia 157
SG - Singapore 145
GB - Regno Unito 104
FR - Francia 43
CA - Canada 35
BE - Belgio 16
NL - Olanda 11
RU - Federazione Russa 11
EU - Europa 10
AU - Australia 9
JP - Giappone 9
MU - Mauritius 8
IN - India 5
RO - Romania 5
TR - Turchia 5
CZ - Repubblica Ceca 4
AT - Austria 3
SA - Arabia Saudita 3
BD - Bangladesh 2
BR - Brasile 2
HK - Hong Kong 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MX - Messico 2
PA - Panama 2
VN - Vietnam 2
AZ - Azerbaigian 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 6.830
Salva come PNG Salva come JPEG
Città #
Chandler 692
Dublin 594
Jacksonville 522
Nanjing 459
Boardman 219
Ashburn 194
Nanchang 176
Princeton 136
Lawrence 131
Wilmington 128
Changsha 126
Hebei 116
Medford 109
Shenyang 107
Helsinki 102
Singapore 93
Jiaxing 92
Beijing 81
Tianjin 72
Ann Arbor 67
Hangzhou 67
New York 52
Milan 44
Pavia 44
Shanghai 34
Woodbridge 30
Toronto 29
Norwalk 25
Brussels 16
Falls Church 16
Verona 16
Seattle 14
Washington 14
Los Angeles 13
Des Moines 11
Kunming 11
Dearborn 10
Fairfield 10
Jinan 10
Zhengzhou 10
San Francisco 9
Taizhou 9
Ningbo 8
Tokyo 8
Guangzhou 6
Houston 6
Santa Clara 6
Dallas 5
Falkenstein 5
Fuzhou 5
Tappahannock 5
Auburn Hills 4
Montecchio Emilia 4
Munich 4
Orange 4
Canberra 3
Chicago 3
Frankfurt am Main 3
Haikou 3
Kemerovo 3
Lanzhou 3
Leawood 3
London 3
Paris 3
Taranto 3
Wuhan 3
Borås 2
Brno 2
Catania 2
Changchun 2
Dhaka 2
Düsseldorf 2
Fayetteville 2
Gießen 2
Haifa 2
Hefei 2
Hengyang 2
Lugo 2
Melbourne 2
Monte di Malo 2
Ottawa 2
Redwood City 2
Vientiane 2
Agra 1
Almaty 1
Amsterdam 1
Andover 1
Baku 1
Baoding 1
Berlin 1
Bolgare 1
Bratislava 1
Buffalo 1
Cairo 1
Central 1
Centurion 1
Changzhou 1
Chisinau 1
Chongqing 1
Desenzano Del Garda 1
Totale 4.864
Salva come PNG Salva come JPEG
Nome #
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts 88
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 83
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. 83
An unusual clinical presentation of multiple myeloma with involvement of the oro-pharynx. 83
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 80
Prognosis of secondary acute myeloid leukemia 79
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 78
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 77
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 76
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella 74
Classification and prognostic evaluation of myelodysplastic syndromes 73
Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation. 73
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 73
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 72
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 71
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. 71
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 70
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 69
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. 69
Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome? 69
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 69
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. 68
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 68
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 67
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 67
CD34 and CD2 expression in acute promyelocytic leukemia. 67
Dendritic cells in acute promyelocytic leukaemia. 66
Myelodysplastic syndromes and bone marrow microenvironment. 66
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 66
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation. 66
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. 65
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes 64
Clinical and biological implications of driver mutations in myelodysplastic syndromes 64
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 63
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 63
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment 63
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells. 63
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 63
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 63
Burkitt-like lymphoma infiltrating a hyperfunctioning thyroid adenoma and presenting as a hot nodule. 62
A rule-based expert system for automatic implementation of somatic variant clinical interpretation guidelines 62
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 61
Hematologic responses with deferasirox therapy in transfusion-dependent myelodysplastic syndromes patients. 61
Ultrastructural and functional differences between normal and tumor endothelial progenitor cells 61
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 60
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 60
Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears. 59
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 59
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome 59
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 59
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. 59
Role of the molecular staging and response in the management of follicular lymphoma patients 58
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings. 58
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. 58
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders 58
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease 57
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 57
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. 56
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. 56
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 56
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective. 56
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 56
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. 55
Simian virus 40 and lymphoproliferative disorder. 55
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients. 55
Risk factors for Gram-negative infections in neutropenic patients. 55
CHARACTERIZATION OF A CELLULAR MODEL FOR THE STUDY OF MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 55
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience. 55
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making 54
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples. 54
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study 54
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 54
Splenectomy for treatment of immune thrombocytopenic purpura. 53
High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene. 53
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 52
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome 51
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival 51
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. 50
Myelodysplastic syndromes with bone marrow fibrosis. 50
Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study. 50
Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. 50
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia 50
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome 49
Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis. 49
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 49
The genetic basis of myelodysplasia and its clinical relevance 49
THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING 47
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. 46
Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes. 46
Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need 46
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype 46
Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors. 45
Remodelling of the Ca2+ signalling machinery in endothelial progenitor cells isolated from breast cancer patients 45
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. 44
Pretransplantation therapy with hypomethylating agents in patients with myelodysplastic syndromes receiving reduced-intensity conditioning regimens. 44
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 44
The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis 44
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 44
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. 44
Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia. 42
Totale 5.979
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 0 14 83 3 124 39 6
2020/2021699 84 64 20 76 7 88 9 117 19 108 90 17
2021/2022651 9 0 21 12 36 20 10 30 39 28 85 361
2022/20231.815 178 102 19 194 201 192 2 129 727 13 34 24
2023/2024665 56 182 28 63 53 175 11 24 3 15 21 34
2024/2025424 61 145 86 39 28 64 1 0 0 0 0 0
Totale 7.018